Pituitary MRI in Cushing's disease - an update

Area of Science:

• Endocrinology
• Radiology
• Neuroimaging

Background:

• Pituitary MRI is vital for diagnosing ACTH-dependent Cushing's syndrome.
• Diagnostic accuracy for corticotropinoma varies significantly (40-90%) based on imaging center and expertise.
• Neuroradiologist expertise, MRI field strength (Tesla 3.0), and sequence selection are critical factors.

Purpose of the Study:

• To review the diagnostic utility of pituitary MRI in ACTH-dependent Cushing's syndrome.
• To highlight the impact of imaging parameters and expertise on diagnostic yield.
• To discuss emerging technologies for improved corticotropinoma detection.

Main Methods:

• Review of current literature on pituitary MRI techniques for Cushing's syndrome.
• Analysis of sequence effectiveness, including T2, 3D gradient echo, spin echo, and FLAIR sequences post-gadolinium.
• Discussion of challenges in diagnosing small adenomas (picoadenomas) and differentiating incidentalomas.

Main Results:

• T2 and 3D gradient echo sequences after gadolinium injection are highly effective for detecting macro- and microadenomas.
• Diagnosing picoadenomas (<3-4 mm) remains challenging, requiring complementary sequences like 2D/3D spin echo or FLAIR.
• Accurate assessment of incidentalomas, excluding artifacts and benign lesions, is crucial.

Conclusions:

• Pituitary MRI, particularly with advanced sequences and skilled interpretation, is essential but faces limitations in detecting small corticotropinomas.
• Differentiating true adenomas from mimics like Rathke's cleft cysts is key.
• Hybrid imaging, such as 11C-methionine PET-MRI, holds promise for future diagnostic improvements.